PURPOSE: Cancer progression is mediated by processes that are also important in wound repair. As a result, cancers have been conceptualized as overhealing wounds or "wounds that do not heal," and gene expression signatures reflective of wound repair have shown value as predictors of breast cancer survival. Despite the widespread acknowledgment of commonalities between host responses to wounds and host responses to cancer, the gene expression responses of normal tissue adjacent to cancers have not been well characterized. EXPERIMENTAL DESIGN: Using RNA extracted from histologically normal breast tissue from 107 patients, including 60 reduction mammoplasty patients and 47 cancer patients, we measured whole genome expression profiles and identified a gene expression signature that is induced in response to breast cancer. RESULTS: This signature represents an in vivo "wound response" signature that is differentially expressed in the normal tissue of breast cancer patients compared with those without disease and is highly accurate (at least 92% sensitivity and 98% specificity) in distinguishing diseased and nondiseased. The in vivo wound response signature is highly prognostic of breast cancer survival, and there is a strong association between the groups identified by this signature and those identified using serum-treated fibroblasts and other microenvironment-derived or microenvironment-related signatures. CONCLUSIONS: The prevalence of the wound response signature in histologically normal tissue adjacent to breast cancer suggests that microenvironment response is an important variable in breast cancer progression and may be an important target for clinical interventions.
PURPOSE:Cancer progression is mediated by processes that are also important in wound repair. As a result, cancers have been conceptualized as overhealing wounds or "wounds that do not heal," and gene expression signatures reflective of wound repair have shown value as predictors of breast cancer survival. Despite the widespread acknowledgment of commonalities between host responses to wounds and host responses to cancer, the gene expression responses of normal tissue adjacent to cancers have not been well characterized. EXPERIMENTAL DESIGN: Using RNA extracted from histologically normal breast tissue from 107 patients, including 60 reduction mammoplasty patients and 47 cancerpatients, we measured whole genome expression profiles and identified a gene expression signature that is induced in response to breast cancer. RESULTS: This signature represents an in vivo "wound response" signature that is differentially expressed in the normal tissue of breast cancerpatients compared with those without disease and is highly accurate (at least 92% sensitivity and 98% specificity) in distinguishing diseased and nondiseased. The in vivo wound response signature is highly prognostic of breast cancer survival, and there is a strong association between the groups identified by this signature and those identified using serum-treated fibroblasts and other microenvironment-derived or microenvironment-related signatures. CONCLUSIONS: The prevalence of the wound response signature in histologically normal tissue adjacent to breast cancer suggests that microenvironment response is an important variable in breast cancer progression and may be an important target for clinical interventions.
Authors: Monica Benito; Joel Parker; Quan Du; Junyuan Wu; Dong Xiang; Charles M Perou; J S Marron Journal: Bioinformatics Date: 2004-01-01 Impact factor: 6.937
Authors: Minna Allinen; Rameen Beroukhim; Li Cai; Cameron Brennan; Jaana Lahti-Domenici; Haiyan Huang; Dale Porter; Min Hu; Lynda Chin; Andrea Richardson; Stuart Schnitt; William R Sellers; Kornelia Polyak Journal: Cancer Cell Date: 2004-07 Impact factor: 31.743
Authors: Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards Journal: N Engl J Med Date: 2002-12-19 Impact factor: 91.245
Authors: Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown Journal: PLoS Biol Date: 2004-01-13 Impact factor: 8.029
Authors: Xuezheng Sun; Patricia Casbas-Hernandez; Carol Bigelow; Liza Makowski; D Joseph Jerry; Sallie Smith Schneider; Melissa A Troester Journal: Breast Cancer Res Treat Date: 2011-10-15 Impact factor: 4.872
Authors: Mauricio P Pinto; Melanie M Badtke; Michelle L Dudevoir; J Chuck Harrell; Britta M Jacobsen; Kathryn B Horwitz Journal: Cancer Res Date: 2010-03-23 Impact factor: 12.701
Authors: Sneha Sundaram; Alex J Freemerman; Amy R Johnson; J Justin Milner; Kirk K McNaughton; Joseph A Galanko; Katharine M Bendt; David B Darr; Charles M Perou; Melissa A Troester; Liza Makowski Journal: Breast Cancer Res Treat Date: 2013-11-12 Impact factor: 4.872
Authors: Amy A Mrazek; Joseph R Carmical; Thomas G Wood; Mark R Hellmich; Mahmoud Eltorky; Frederick J Bohanon; Celia Chao Journal: Curr Cancer Ther Rev Date: 2014-01
Authors: Heather Ann Brauer; Liza Makowski; Katherine A Hoadley; Patricia Casbas-Hernandez; Lindsay J Lang; Erick Romàn-Pèrez; Monica D'Arcy; Alex J Freemerman; Charles M Perou; Melissa A Troester Journal: Clin Cancer Res Date: 2012-12-12 Impact factor: 12.531
Authors: Kelly Graham; Xijin Ge; Antonio de Las Morenas; Anusri Tripathi; Carol L Rosenberg Journal: Clin Cancer Res Date: 2010-11-08 Impact factor: 12.531
Authors: Mark E Sherman; Jonine D Figueroa; Jill E Henry; Susan E Clare; Connie Rufenbarger; Anna Maria Storniolo Journal: Cancer Prev Res (Phila) Date: 2012-02-17
Authors: Milan Radovich; Susan E Clare; Rutuja Atale; Ivanesa Pardo; Bradley A Hancock; Jeffrey P Solzak; Nawal Kassem; Theresa Mathieson; Anna Maria V Storniolo; Connie Rufenbarger; Heather A Lillemoe; Rachel J Blosser; Mi Ran Choi; Candice A Sauder; Diane Doxey; Jill E Henry; Eric E Hilligoss; Onur Sakarya; Fiona C Hyland; Matthew Hickenbotham; Jin Zhu; Jarret Glasscock; Sunil Badve; Mircea Ivan; Yunlong Liu; George W Sledge; Bryan P Schneider Journal: Breast Cancer Res Treat Date: 2013-11-29 Impact factor: 4.872